Paolo Gavarotti

Erratum: Early Chemotherapy Intensification With Escalated BEACOPP in Patients With Advanced-Stage Hodgkin Lymphoma With a Positive Interim Positron Emission Tomography/Computed Tomography Scan After Two ABVD Cycles: Long-Term Results of the GITIL/FIL HD 0607 Trial

Andrea Gallamini, Corrado Tarella, Simonetta Viviani, Andrea Rossi et autres

Lesion Dissemination in Baseline PET/CT (D-MAX) and IPS Score Predict ABVD Treatment Outcome in PET-2 Negative Advanced-Stage Hodgkin Lymphoma Patients Enrolled in the Prospective GITIL/FIL HD0607 Trial

Andrea Gallamini, Alessandro Rambaldi, Caterina Patti, Alessandra Romano et autres

fr, it (code pays fourni par la source)

BASELINE METABOLIC TUMOR VOLUME AND IPS PREDICT ABVD FAILURE IN ADVANCED‐STAGE HODGKIN LYMPHOMA WITH A NEGATIVE INTERIM PET SCAN AFTER 2 CHEMOTHERAPY CYCLES. A RETROSPECTIVE ANALYSIS FROM THE GITIL/FIL HD0607 TRIAL

Andrea Gallamini, Alessandro Rambaldi, Caterina Patti, Alessandra Romano et autres

fr, it (code pays fourni par la source)

The neutrophil to lymphocyte ratio (NLR) and the presence of large nodal mass are independent predictors of early response: A subanalysis of the prospective phase II PET‐2‐adapted HD0607 trial

Alessandra Romano, Chiara Pavoni, Francesco Di Raimondo, Corrado Tarella et autres

it, fr (code pays fourni par la source)

CONSOLIDATION RADIOTHERAPY COULD BE OMITTED IN ADVANCED HODGKIN LYMPHOMA WITH LARGE NODAL MASS IN COMPLETE METABOLIC RESPONSE AFTER ABVD. FINAL ANALYSIS OF THE RANDOMIZED HD0607 TRIAL

Andrea Gallamini, Andrea Rossi, Caterina Patti, Marco Picardi et autres

fr, it, il (code pays fourni par la source)

Prognostic Relevance of Neutrophil to Lymphocyte Ratio (NLR) and Lymphocyte to Monocyte Ratio (LMR) in Newly Diagnosed Advanced-Stage Hodgkin Lymphoma Patients Treated up-Front with a PET-2 Risk Adapted Protocol

Alessandra Romano, Francesco Di Raimondo, Chiara Pavoni, Corrado Tarella et autres

it, fr (code pays fourni par la source)

Early Chemotherapy Intensification With Escalated BEACOPP in Patients With Advanced-Stage Hodgkin Lymphoma With a Positive Interim Positron Emission Tomography/Computed Tomography Scan After Two ABVD Cycles: Long-Term Results of the GITIL/FIL HD 0607 Trial

Andrea Gallamini, Corrado Tarella, Simonetta Viviani, Andrea Rossi et autres

it (code pays fourni par la source)

Potential Benefit of Involved-Field Radiotherapy for Patients With Relapsed-Refractory Hodgkin's Lymphoma With Incomplete Response Before Autologous Stem Cell Transplantation

Mario Levis, Cristina Piva, Andrea Riccardo Filippi, Barbara Botto et autres

it (code pays fourni par la source)

PV-0279: Role of IFRT prior or after autologous stem cell rescue for refractory or relapsed Hodgkin lymphoma

Mark J. Levis, Cristina Piva, Andrea Riccardo Filippi, Patrizia Pregno et autres

it (code pays fourni par la source)

Salvage treatment for relapsed/refractory Hodgkin lymphoma: role of allografting, brentuximab vedotin and newer agents

Massimo Martino, Moreno Festuccia, Roberta Fedele, Giuseppe Console et autres

it (code pays fourni par la source)

Involved-Site Image-Guided Intensity Modulated Versus 3D Conformal Radiation Therapy in Early Stage Supradiaphragmatic Hodgkin Lymphoma

Andrea Riccardo Filippi, Patrizia Ciammella, Cristina Piva, Riccardo Ragona et autres

it (code pays fourni par la source)

Upstaging by PET-ascertained bone and bone marrow involvement in Hodgkin lymphoma:definitions matter

Anna Borra, Tarec Christoffer El‐Galaly, Jan Maciej Zaucha, Luigi Rigacci et autres

dk, us, ca (code pays fourni par la source)